Skip to content

Unity Biotechnology, Inc.

CIK 0001463361

← back to feed
Revenue (TTM)
$236K
Q1 Apr 2025
Net Income (TTM)
−$24.85M
+34.8% YoY Q1 Apr 2025
EPS Diluted (TTM)
−$1.46
+43.0% YoY Q1 Apr 2025
Gross Margin
—
Q1 Apr 2025
Operating Margin
-11,894.5%
Q1 Apr 2025
Net Margin
-10,530.5%
Q1 Apr 2025
Free Cash Flow (TTM)
−$38.08M
Q1 Apr 2025
Cash
$8M
Q1 Apr 2025
Total Debt
$0
Q1 Apr 2025
Shares Outstanding
17.21M sh
Q1 Apr 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings